<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24231751</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>Human vaccines &amp; immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>Coxsackievirus A16: epidemiology, diagnosis, and vaccine.</ArticleTitle><Pagination><StartPage>360</StartPage><EndPage>367</EndPage><MedlinePgn>360-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4161/hv.27087</ELocationID><Abstract><AbstractText>Coxsackievirus 16 (CA16) is one of the major pathogens associated with hand, foot, and mouth disease (HFMD) in infants and young children. In recent years, CA16 and human enterovirus 71 (EV71) have often circulated alternatively or together in the Western Pacific region, which has become an important public health problem in this region. HFMD caused by CA16 infection is generally thought to be mild and self-limiting. However, recently several severe and fatal cases involving CA16 have been reported. Studies have shown that co-infection with CA16 and EV71 can cause serious complications in the central nervous system (CNS) and increase the chance of genetic recombination, which may be responsible for the large HFMD outbreak in Mainland China in 2008. For these reasons, recent studies have focused on the virological characteristics of CA16 and the development of CA16-related diagnostic reagents and vaccines.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Qunying</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control; Beijing, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yiping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control; Beijing, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control; Beijing, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bian</LastName><ForeName>Lianlian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control; Beijing, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control; Beijing, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Miao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control; Beijing, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Zhenglun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>National Institutes for Food and Drug Control; Beijing, PR China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019411" MajorTopicYN="N">Clinical Laboratory Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003955" MajorTopicYN="N">Diagnostic Tests, Routine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coxsackievirus A16 (CA16)</Keyword><Keyword MajorTopicYN="N">animal model</Keyword><Keyword MajorTopicYN="N">neutralizing antibody</Keyword><Keyword MajorTopicYN="N">recombination</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24231751</ArticleId><ArticleId IdType="pmc">PMC4185891</ArticleId><ArticleId IdType="doi">10.4161/hv.27087</ArticleId><ArticleId IdType="pii">27087</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sickles GM, Mutterer M, Feorino P, Plager H. Recently classified types of Coxsackie virus, group A; behavior in tissue culture. Proc Soc Exp Biol Med. 1955;90:529&#x2013;31. doi: 10.3181/00379727-90-22088.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/00379727-90-22088</ArticleId><ArticleId IdType="pubmed">13273503</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S, Singh S, Poh CL, Chow VT. The hand, foot and mouth disease virus capsid: sequence analysis and prediction of antigenic sites from homology modelling. Appl Bioinformatics. 2002;1:43&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">15130856</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou XN, Zhang XZ, Wang B, Qiu YT. Etiologic and epidemiologic analysis of hand, foot, and mouth disease in Guangzhou city: a review of 4,753 cases. Braz J Infect Dis. 2012;16:457&#x2013;65. doi: 10.1016/j.bjid.2012.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjid.2012.08.001</ArticleId><ArticleId IdType="pubmed">22964289</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Huang X, Liu Q, Huang Z. Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16. Vaccine. 2013;31:2130&#x2013;6. doi: 10.1016/j.vaccine.2013.02.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.02.051</ArticleId><ArticleId IdType="pubmed">23499595</ArticleId></ArticleIdList></Reference><Reference><Citation>Goto K, Sanefuji M, Kusuhara K, Nishimura Y, Shimizu H, Kira R, Torisu H, Hara T. Rhombencephalitis and coxsackievirus A16. Emerg Infect Dis. 2009;15:1689&#x2013;91. doi: 10.3201/eid1510.090594.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1510.090594</ArticleId><ArticleId IdType="pmc">PMC2866411</ArticleId><ArticleId IdType="pubmed">19861078</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CY, Li Lu F, Wu MH, Lee CY, Huang LM. Fatal coxsackievirus A16 infection. Pediatr Infect Dis J. 2004;23:275&#x2013;6. doi: 10.1097/01.inf.0000115950.63906.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000115950.63906.78</ArticleId><ArticleId IdType="pubmed">15014311</ArticleId></ArticleIdList></Reference><Reference><Citation>Legay F, L&#xe9;v&#xea;que N, Gacouin A, Tattevin P, Bouet J, Thomas R, Chomelt JJ. Fatal coxsackievirus A-16 pneumonitis in adult. Emerg Infect Dis. 2007;13:1084&#x2013;6. doi: 10.3201/eid1307.070295.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1307.070295</ArticleId><ArticleId IdType="pmc">PMC2878248</ArticleId><ArticleId IdType="pubmed">18214187</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson CR, Doane FW, Rhodes AJ. Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957; isolation of group A Coxsackie virus. Can Med Assoc J. 1958;79:615&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1830188</ArticleId><ArticleId IdType="pubmed">13585281</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferson MJ, Bell SM. Outbreak of Coxsackievirus A16 hand, foot, and mouth disease in a child day-care center. Am J Public Health. 1991;81:1675&#x2013;6. doi: 10.2105/AJPH.81.12.1675.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.81.12.1675</ArticleId><ArticleId IdType="pmc">PMC1405294</ArticleId><ArticleId IdType="pubmed">1746672</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendig JW, Fleming DM. Epidemiological, virological, and clinical features of an epidemic of hand, foot, and mouth disease in England and Wales. Commun Dis Rep CDR Rev. 1996;6:R81&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8664928</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY. Enterovirus 71 in Taiwan. Pediatr Neonatol. 2008;49:103&#x2013;12. doi: 10.1016/S1875-9572(08)60023-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1875-9572(08)60023-6</ArticleId><ArticleId IdType="pubmed">19054914</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang LW, Koh BK, Chan KP, Chua LT, James L, Goh KT. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann Acad Med Singapore. 2009;38:106&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">19271036</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu PV, Thao NT, Perera D, Huu TK, Tien NT, Thuong TC, How OM, Cardosa MJ, McMinn PC. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis. 2007;13:1733&#x2013;41. doi: 10.3201/eid1311.070632.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1311.070632</ArticleId><ArticleId IdType="pmc">PMC3375788</ArticleId><ArticleId IdType="pubmed">18217559</ArticleId></ArticleIdList></Reference><Reference><Citation>Kar BR, Dwibedi B, Kar SK. An outbreak of hand, foot and mouth disease in Bhubaneswar, Odisha. Indian Pediatr. 2013;50:139&#x2013;42. doi: 10.1007/s13312-013-0033-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13312-013-0033-0</ArticleId><ArticleId IdType="pubmed">22728634</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Luo Z, Wang J, Xu Z, Chen H, Fan D, Gao N, Ping G, Zhou Z, Zhang Y, et al. Phylogenetic analysis of Enterovirus 71 circulating in Beijing, China from 2007 to 2009. PLoS One. 2013;8:e56318. doi: 10.1371/journal.pone.0056318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0056318</ArticleId><ArticleId IdType="pmc">PMC3572022</ArticleId><ArticleId IdType="pubmed">23418551</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Trials [Internet]. A protected study of inactivated EV71 vaccine (human diploid cell, KMB-17) in Chinese infants and children. 2013. Available from: http://clinicaltrials.gov/show/NCT01569581</Citation></Reference><Reference><Citation>Positive topline results from Phase III trial of Enterovirus 71 vaccine (Sinovac Biotech) against Hand, Foot and Mouth Disease. 2013. http://www.sinovac.com/?optionid=754&amp;auto_id=715</Citation></Reference><Reference><Citation>Zhu FC, Meng FY, Li JX, Li XL, Mao QY, Tao H, Zhang YT, Yao X, Chu K, Chen QH, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381:2024&#x2013;32. doi: 10.1016/S0140-6736(13)61049-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61049-1</ArticleId><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright HT, Jr., Landing BH, Lennette EH, McALLISTER RM. Fatal infection in an infant associated with Coxsackie virus group A, type 16. N Engl J Med. 1963;268:1041&#x2013;4. doi: 10.1056/NEJM196305092681904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM196305092681904</ArticleId><ArticleId IdType="pubmed">14001956</ArticleId></ArticleIdList></Reference><Reference><Citation>WS Y. Clinical characteristic analysis of 104 cases of children severe hand, foot and mouth disease. Chongqing Med. 2011;40:6.</Citation></Reference><Reference><Citation>Xu W, Liu CF, Yan L, Li JJ, Wang LJ, Qi Y, Cheng RB, Xiong XY. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol J. 2012;9:8. doi: 10.1186/1743-422X-9-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-8</ArticleId><ArticleId IdType="pmc">PMC3268717</ArticleId><ArticleId IdType="pubmed">22230340</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao K, Han X, Wang G, Hu W, Zhang W, Yu XF. Circulating coxsackievirus A16 identified as recombinant type A human enterovirus, China. Emerg Infect Dis. 2011;17:1537&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3381541</ArticleId><ArticleId IdType="pubmed">21801645</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HMLC, Li CR, Liu YJ, Liu WL, Fu D, Xu LM, Xie JJ, Tan Y, Wang H, Chen XC, et al. [To investigate pathogen of hand, foot and mouth disease in Shenzhen in 2008] Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009;23:334&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20387478</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan H, Zhu YF, Qi X, Zhang YJ, Li L, Deng F, Wu B, Wang SJ, Zhu FC, Wang H. [Analysis on the epidemiological and genetic characteristics of enterovirus type 71 and Coxsackie A16 virus infection in Jiangsu, China] Zhonghua Liu Xing Bing Xue Za Zhi. 2009;30:339&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">19731523</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip CC, Lau SK, Zhou B, Zhang MX, Tsoi HW, Chan KH, Chen XC, Woo PC, Yuen KY. Emergence of enterovirus 71 &#x201c;double-recombinant&#x201d; strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71. Arch Virol. 2010;155:1413&#x2013;24. doi: 10.1007/s00705-010-0722-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-010-0722-0</ArticleId><ArticleId IdType="pmc">PMC7087135</ArticleId><ArticleId IdType="pubmed">20549263</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, Mao N, Xu S, Zhu S, Cui A, et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J. 2010;7:94. doi: 10.1186/1743-422X-7-94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-94</ArticleId><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Yan K, Feng Y, Huang X, Ku Z, Cai Y, Liu F, Shi J, Huang Z. A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge. Vaccine. 2012;30:6642&#x2013;8. doi: 10.1016/j.vaccine.2012.08.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.08.071</ArticleId><ArticleId IdType="pubmed">22959985</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y, Liu Q, Huang X, Li D, Ku Z, Zhang Y, Huang Z. Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection. Vaccine. 2013;31:2215&#x2013;21. doi: 10.1016/j.vaccine.2013.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.03.007</ArticleId><ArticleId IdType="pubmed">23499596</ArticleId></ArticleIdList></Reference><Reference><Citation> http://www.cdc.gov.tw</Citation></Reference><Reference><Citation>Zhu Z, Zhu S, Guo X, Wang J, Wang D, Yan D, Tan X, Tang L, Zhu H, Yang Z, et al. Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008. Virol J. 2010;7:300. doi: 10.1186/1743-422X-7-300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-300</ArticleId><ArticleId IdType="pmc">PMC2989968</ArticleId><ArticleId IdType="pubmed">21050463</ArticleId></ArticleIdList></Reference><Reference><Citation> http://www.chinacdc.cn/tjsj/fdcrbbg/</Citation></Reference><Reference><Citation>Iwai M, Masaki A, Hasegawa S, Obara M, Horimoto E, Nakamura K, Tanaka Y, Endo K, Tanaka K, Ueda J, et al. Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007. Jpn J Infect Dis. 2009;62:254&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19628900</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, He Y, Yang H, Zhu J, Xu X, Dong J, Zhu Y, Jin Q. Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People&#x2019;s Republic of China. J Clin Microbiol. 2005;43:3835&#x2013;9. doi: 10.1128/JCM.43.8.3835-3839.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.43.8.3835-3839.2005</ArticleId><ArticleId IdType="pmc">PMC1233905</ArticleId><ArticleId IdType="pubmed">16081920</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Twu SJ, Ho MS, Chang LY, Lee CY. Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg Infect Dis. 2003;9:291&#x2013;3. doi: 10.3201/eid0903.020285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0903.020285</ArticleId><ArticleId IdType="pmc">PMC2963902</ArticleId><ArticleId IdType="pubmed">12643822</ArticleId></ArticleIdList></Reference><Reference><Citation>Podin Y, Gias EL, Ong F, Leong YW, Yee SF, Yusof MA, Perera D, Teo B, Wee TY, Yao SC, et al. Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health. 2006;6:180. doi: 10.1186/1471-2458-6-180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-6-180</ArticleId><ArticleId IdType="pmc">PMC1543637</ArticleId><ArticleId IdType="pubmed">16827926</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W, et al. Genetic analysis and etiology study of hand-foot mouth disease in surveillance hospitals of Hunan province during the period of 2008-2010. Pract Prev Med. 2011;18:779&#x2013;84.</Citation></Reference><Reference><Citation>Jia L, Zhao CS, Zhang L, Li S, Zhang DT, Liu BW, Wang QY, Li XY. [Comparisons of epidemiological and clinical characteristics in children with hand-foot-mouth disease caused by Enterovirus 71 and Coxackievirus A16] Zhongguo Dang Dai Er Ke Za Zhi. 2011;13:635&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21849112</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye RXZY, Pan KN, Tong YX. Significance of enterovirus 71 and coxsackievirus 16 pathogens detection in preventing epidemics of hand, foot and mouth disease. Chin J Nosocomiol. 2011;21:1295&#x2013;6.</Citation></Reference><Reference><Citation>Zhang YJBJ, Huang XL. Clinical analysis of 54 cases of hand, foot and mouth disease with central nervous system damage. Chin J CritCare Med. 2010;30:1090&#x2013;2.</Citation></Reference><Reference><Citation>Zhang W, et al Severe hand, foot, and mouth disease caused by mixed infection of enterovirus 71 and coxsackie A16: report of 6 cases. Chin Gen Practice. 2011;14:3341&#x2013;6.</Citation></Reference><Reference><Citation>Zhang Y, Wang D, Yan D, Zhu S, Liu J, Wang H, Zhao S, Yu D, Nan L, An J, et al. Molecular evidence of persistent epidemic and evolution of subgenotype B1 coxsackievirus A16-associated hand, foot, and mouth disease in China. J Clin Microbiol. 2010;48:619&#x2013;22. doi: 10.1128/JCM.02338-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02338-09</ArticleId><ArticleId IdType="pmc">PMC2815627</ArticleId><ArticleId IdType="pubmed">20018819</ArticleId></ArticleIdList></Reference><Reference><Citation>Zong W, He Y, Yu S, Yang H, Xian H, Liao Y, Hu G. Molecular phylogeny of Coxsackievirus A16 in Shenzhen, China, from 2005 to 2009. J Clin Microbiol. 2011;49:1659&#x2013;61. doi: 10.1128/JCM.00010-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00010-11</ArticleId><ArticleId IdType="pmc">PMC3122795</ArticleId><ArticleId IdType="pubmed">21325543</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Kong F, Wang B, McPhie K, Gilbert GL, Dwyer DE. Molecular characterization of enterovirus 71 and coxsackievirus A16 using the 5&#x2032; untranslated region and VP1 region. J Med Microbiol. 2011;60:349&#x2013;58. doi: 10.1099/jmm.0.025056-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.025056-0</ArticleId><ArticleId IdType="pubmed">21148280</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera D, Yusof MA, Podin Y, Ooi MH, Thao NT, Wong KK, Zaki A, Chua KB, Malik YA, Tu PV, et al. Molecular phylogeny of modern coxsackievirus A16. Arch Virol. 2007;152:1201&#x2013;8. doi: 10.1007/s00705-006-0934-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-006-0934-5</ArticleId><ArticleId IdType="pubmed">17308978</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Oberste MS, Alexander JP, Jr., Kennett ML, Pallansch MA. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol. 1999;73:9969&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113047</ArticleId><ArticleId IdType="pubmed">10559310</ArticleId></ArticleIdList></Reference><Reference><Citation>Phuektes P, Chua BH, Sanders S, Bek EJ, Kok CC, McMinn PC. Mapping genetic determinants of the cell-culture growth phenotype of enterovirus 71. J Gen Virol. 2011;92:1380&#x2013;90. doi: 10.1099/vir.0.029371-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.029371-0</ArticleId><ArticleId IdType="pmc">PMC3168283</ArticleId><ArticleId IdType="pubmed">21346025</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang E, Zhao H, Zhang Y, Liu J, Liao Y, Wang L, Cui P, Yang L, Liu L, Dong C, et al. A comparative study of the characteristics of two Coxsackie A virus type 16 strains (genotype B). Science China. Life Sci. 2012;55:336&#x2013;42. doi: 10.1007/s11427-012-4313-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-012-4313-z</ArticleId><ArticleId IdType="pubmed">22566090</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni H, Yi B, Yin J, Fang T, He T, Du Y, Wang J, Zhang H, Xie L, Ding Y, et al. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Ningbo, China, 2008-2011. J Clin Virol. 2012;54:342&#x2013;8. doi: 10.1016/j.jcv.2012.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2012.04.021</ArticleId><ArticleId IdType="pubmed">22652041</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu FC, Liang ZL, Meng FY, Zeng Y, Mao QY, Chu K, Song XF, Yao X, Li JX, Ji H, et al. Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. PLoS One. 2012;7:e37206. doi: 10.1371/journal.pone.0037206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037206</ArticleId><ArticleId IdType="pmc">PMC3360679</ArticleId><ArticleId IdType="pubmed">22662137</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabenau HF, Richter M, Doerr HW. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol. 2010;199:45&#x2013;51. doi: 10.1007/s00430-009-0133-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-009-0133-6</ArticleId><ArticleId IdType="pubmed">19941005</ArticleId></ArticleIdList></Reference><Reference><Citation>Diedrich S, Weinbrecht A, Schreier E. Seroprevalence and molecular epidemiology of enterovirus 71 in Germany. Arch Virol. 2009;154:1139&#x2013;42. doi: 10.1007/s00705-009-0413-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-009-0413-x</ArticleId><ArticleId IdType="pubmed">19506798</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, King CC, Hsu KH, Ning HC, Tsao KC, Li CC, Huang YC, Shih SR, Chiou ST, Chen PY, et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics. 2002;109:e88. doi: 10.1542/peds.109.6.e88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.109.6.e88</ArticleId><ArticleId IdType="pubmed">12042582</ArticleId></ArticleIdList></Reference><Reference><Citation>Kung SH, Wang SF, Huang CW, Hsu CC, Liu HF, Yang JY. Genetic and antigenic analyses of enterovirus 71 isolates in Taiwan during 1998-2005. Clin Microbiol Infect. 2007;13:782&#x2013;7. doi: 10.1111/j.1469-0691.2007.01745.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2007.01745.x</ArticleId><ArticleId IdType="pubmed">17488328</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J, Ma H, Xu L, An D, Sun S, Huang X, Kong W, Jiang C. Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum. J Virol Methods. 2013;187:362&#x2013;7. doi: 10.1016/j.jviromet.2012.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2012.11.014</ArticleId><ArticleId IdType="pmc">PMC7112850</ArticleId><ArticleId IdType="pubmed">23178532</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu N, Guo M, He SJ, Pan YX, Chen XX, Ding XX, Hao W, Wang YD, Ge SX, Xia NS, et al. Evaluation of human enterovirus 71 and coxsackievirus A16 specific immunoglobulin M antibodies for diagnosis of hand-foot-and-mouth disease. Virol J. 2012;9:12. doi: 10.1186/1743-422X-9-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-12</ArticleId><ArticleId IdType="pmc">PMC3296593</ArticleId><ArticleId IdType="pubmed">22234169</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu D, Zhao XY, Yao Y, Dai FF, He H, Li RQ, Jin RH, Liang LC, Li N. A new factor influencing pathogen detection by molecular assay in children with both mild and severe hand, foot, and mouth disease. Diagn Microbiol Infect Dis. 2013;76:162&#x2013;7. doi: 10.1016/j.diagmicrobio.2013.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2013.02.011</ArticleId><ArticleId IdType="pmc">PMC7126308</ArticleId><ArticleId IdType="pubmed">23535205</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Pallansch MA. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 1995;39:195&#x2013;205. doi: 10.1016/0168-1702(95)00087-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00087-9</ArticleId><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F, He D, He S, Wu B, Guan L, Niu J, Li L, Li C, Weng Z, Yan Q, et al. Development of an IgM-capture ELISA for Coxsackievirus A16 infection. J Virol Methods. 2011;171:107&#x2013;10. doi: 10.1016/j.jviromet.2010.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2010.10.009</ArticleId><ArticleId IdType="pubmed">20970457</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Chow VT, Phoon MC, Chan KP, Poh CL. Direct detection of enterovirus 71 (EV71) in clinical specimens from a hand, foot, and mouth disease outbreak in Singapore by reverse transcription-PCR with universal enterovirus and EV71-specific primers. J Clin Microbiol. 2002;40:2823&#x2013;7. doi: 10.1128/JCM.40.8.2823-2827.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.40.8.2823-2827.2002</ArticleId><ArticleId IdType="pmc">PMC120643</ArticleId><ArticleId IdType="pubmed">12149336</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HMJ, Ma XM. Analysis of etiology detection result of HFMD cases in Ningxia in2008. Ningxia Med J. 2009;33:515&#x2013;6.</Citation></Reference><Reference><Citation>Jiang B, Zhang J, You X, Dong C, Cheng X, Dai X, Meng J. Diagnosis of hand, foot, and mouth disease caused by EV71 and other enteroviruses by a one-step, single tube, duplex RT-PCR. J Med Virol. 2012;84:1803&#x2013;8. doi: 10.1002/jmv.23391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23391</ArticleId><ArticleId IdType="pubmed">22997084</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Zhang T, Hu Y, Wang X, Du J, Li Y, Sun S, Sun X, Li Z, Jin Q. Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009. Virol J. 2011;8:508. doi: 10.1186/1743-422X-8-508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-508</ArticleId><ArticleId IdType="pmc">PMC3227625</ArticleId><ArticleId IdType="pubmed">22054534</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EL, Chow VT, Quak SH, Yeo WC, Poh CL. Development of multiplex real-time hybridization probe reverse transcriptase polymerase chain reaction for specific detection and differentiation of Enterovirus 71 and Coxsackievirus A16. Diagn Microbiol Infect Dis. 2008;61:294&#x2013;301. doi: 10.1016/j.diagmicrobio.2008.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2008.02.009</ArticleId><ArticleId IdType="pubmed">18394844</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TC, Chen GW, Hsiung CA, Yang JY, Shih SR, Lai YK, Juang JL. Combining multiplex reverse transcription-PCR and a diagnostic microarray to detect and differentiate enterovirus 71 and coxsackievirus A16. J Clin Microbiol. 2006;44:2212&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1489440</ArticleId><ArticleId IdType="pubmed">16757623</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L, Sun S, Li B, Pan Y, Li W, Zhang K, Li J. External quality assessment for enterovirus 71 and coxsackievirus A16 detection by reverse transcription-PCR using armored RNA as a virus surrogate. J Clin Microbiol. 2011;49:3591&#x2013;5. doi: 10.1128/JCM.00686-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00686-11</ArticleId><ArticleId IdType="pmc">PMC3187324</ArticleId><ArticleId IdType="pubmed">21865426</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhu JP, Zhang Q, Xu ZG, Zhang F, Zhao ZH, Zheng WZ, Zheng LS. Detection of enterovirus 71 using reverse transcription loop-mediated isothermal amplification (RT-LAMP) J Virol Methods. 2012;179:330&#x2013;4. doi: 10.1016/j.jviromet.2011.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2011.11.019</ArticleId><ArticleId IdType="pubmed">22155579</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Wang Y, Gao R, Shao J, Yao X, Lang S, Wang C, Mao P, Liang Z, Wang J. A neonatal mouse model of coxsackievirus A16 for vaccine evaluation. J Virol. 2012;86:11967&#x2013;76. doi: 10.1128/JVI.00902-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00902-12</ArticleId><ArticleId IdType="pmc">PMC3486452</ArticleId><ArticleId IdType="pubmed">22951825</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Liu Q, Cai Y, Leng Q, Huang Z. Construction and characterization of an infectious clone of coxsackievirus A16. Virol J. 2011;8:534. doi: 10.1186/1743-422X-8-534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-534</ArticleId><ArticleId IdType="pmc">PMC3283524</ArticleId><ArticleId IdType="pubmed">22165961</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Ku Z, Cai Y, Sun B, Leng Q, Huang Z. Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins. J Virol Methods. 2011;173:115&#x2013;20. doi: 10.1016/j.jviromet.2011.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2011.01.016</ArticleId><ArticleId IdType="pubmed">21295614</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J, Theamboonlers A, Korkong S, Linsuwanon P, Thongmee C, Chatproedprai S, Poovorawan Y. Molecular characterization and complete genome analysis of human enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Thailand during 2008-2011. Arch Virol. 2011;156:2007&#x2013;13. doi: 10.1007/s00705-011-1098-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-011-1098-5</ArticleId><ArticleId IdType="pubmed">21898187</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiaoyun F, Xiongfei J, Lihuan L, Angao X. Epidemiology and etiological characteristics of hand, foot and mouth disease in Huizhou City between 2008 and 2011. Arch Virol. 2013;158:895&#x2013;9. doi: 10.1007/s00705-012-1566-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-012-1566-6</ArticleId><ArticleId IdType="pubmed">23229012</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Fan G, Xia W, He F, Hu M, Ni X, Zhang Y, Chen H. Molecular epidemiology of human enterovirus 71 strains in the Nanchang region of China in 2011. Jpn J Infect Dis. 2013;66:149&#x2013;50. doi: 10.7883/yoken.66.149.</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken.66.149</ArticleId><ArticleId IdType="pubmed">23514913</ArticleId></ArticleIdList></Reference><Reference><Citation>Urquhart GE. A survey of coxsackie A16 virus antibodies in human sera. J Hyg (Lond) 1984;93:205&#x2013;12. doi: 10.1017/S002217240006472X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S002217240006472X</ArticleId><ArticleId IdType="pmc">PMC2129431</ArticleId><ArticleId IdType="pubmed">6094661</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Wen K, Pan Y, Wang Y, Che X, Wang B. Cross-reactivity of anti-EV71 IgM and neutralizing antibody in series sera of patients infected with Enterovirus 71 and Coxsackievirus A 16. J Immunoassay Immunochem. 2011;32:233&#x2013;43. doi: 10.1080/15321819.2011.559297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15321819.2011.559297</ArticleId><ArticleId IdType="pubmed">21574094</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>